AREG and crescentic glomerulonephritis: These authors also found a strong upregulation of renal AREG expression in human crescentic glomerulonephritis (Melderis et al., 2020) and thereby suggesting that AREG/EGFR axis might represent a new therapeutic target for patients with acute glomerulonephritis.